ALBUQUERQUE, N.M. & FRAMINGHAM, Mass.--(BUSINESS WIRE)--TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has closed an expanded A-1 $2.1 million venture and angel investor interim funding round to support continued product commercialization and new technology development.
The expanded round was led by the Verge Fund (Albuquerque, N.M.), with participation by Boston-based Launchpad Venture Group and Albuquerque-based Synergy Ventures, as well as Fort Washington Investment Advisors, and Santa Fe-based Jerome Capital and included individual private investors, as well as Takata and KS Centoco as strategic investors.
Dr. Richard D. Gill, President and CEO of TruTouch, said, "We are delighted to announce the closure of this oversubscribed expanded financing round, which will help advance commercialization of our current TruTouch intoxication detection systems, which are already enjoying success in the law enforcement support, oil drilling, military and transportation operation workplace markets. Additionally, our next-generation finger touch system, the TruTouch 2000, has proceeded successfully through development and clinical calibration trials, and we have been successfully placing into the workplace, and will then look to medical, point of sale and automotive OEM partners."
He added, "TruTouch's mission is to help eliminate alcohol-related dangers in our workplaces and on our roadways, by providing a simple, accurate and cost-effective biometric intoxication test to ensure worker and driver and equipment operator safety."
The TruTouch Guardian is an advanced intoxication detection device that uses light to measure a subject's alcohol level instead of bodily fluids or other means. With the TruTouch Guardian, a test subject places his or her arm on an infrared scanning system, which then analyzes the level of intoxicant in the subject's system. The device can produce accurate results in less than a minute, and has a built-in biometric identification system to ensure test result integrity. The TruTouch 2000 is a finger touch device that currently can provide analysis in 15 seconds and is now being developed toward a portable format, the TruTouch 3000.
Unlike a Breathalyzer, the TruTouch Guardian and TruTouch 2000 and 3000 devices require no user training, no disposables, no samples, and no operator assistance is required.
Current and future TruTouch applications include:
- Workplace Safety Systems
- Medical Diagnostic Systems
- Alcohol Point-Of-Sale Liability Reduction Systems
- Law Enforcement Systems
- Industrial Safety Systems
- Vehicle Automotive Safety Systems
About TruTouch Technologies
TruTouch Technologies, Inc. develops, manufactures and sells patented noninvasive biometric alcohol testing systems into both existing and emerging alcohol testing markets. Inspired by the potential to place its passive, durable systems virtually anywhere, TruTouch's vision is to create a world where intoxication is routinely intercepted before it does harm.